Valeant stocks fall due to CEO's medical leave

LAVAL, Que. -- Valeant Pharmaceuticals stock fell about 11 per cent on the Toronto Stock Exchange on Tuesday, the first day the market was open since the embattled drug company announced that CEO Michael Pearson took a medical leave of absence.

See Full Article

Shares of Canada's largest drugmaker (TSX:VRX, NYSE:VRX) fell about 10 per cent Monday in New York to close at US$102.14 following its announcement that Pearson was being treated in hospital for pneumonia.

The stock regained some ground overnight but fell even further when regular trade resumed Tuesday.

The shares were down US$1.66 or 1.6 per cent at US$100.48 on the New York Stock Exchange and down C$18.21 or 11.6 per cent from Thursday's close on the TSX, before the holiday weekend.

Valeant announced Monday that Pearson's duties will be shared on an interim basis between Robert Chai-Onn, Valeant's general counsel, as well as board chairman Ari Kellen and chief financial officer Robert Rosiello.

The company, headquartered in Laval, Que., has been facing a series of scandals that have slashed its stock price by more than half since record highs posted in August.

Pearson himself had been facing criticism and recently struck a defiant tone after calls for his dismissal surfaced.

"If the board wants to fire me they are welcome to fire me, but until they do we're going to get through this thing," Pearson told investors during a Dec. 16 webcast.

The company is facing a congressional investigation in the U.S. over its pricing practices and has been forced to revise its 2016 outlook after ending a drug distribution agreement with Philidor, a U.S. mail-order pharmacy.

Valeant said on Dec. 16 that the October split from Philidor caused a big short-term disruption to its business that would reduce its expectations for the fourth quarter and 2015 as a whole.

But Pearson indicated that a new distribution agreement with major U.S. drug store chain Walgreens had set the company back on the road to recovery.

Pearson, 56, joined Valeant in 2008 after a 23-year career with the consulting firm McKinsey & Co., for which he served as head of its global pharmaceutical practice.

He used a string of acquisitions to turn a relatively small business that made generic drugs and chronic illness treatments into a major pharmaceutical company.

Valeant, formerly based in California, combined with Canadian drugmaker Biovail in 2010 and moved the head office to Mississauga, Ont., and later to Laval near Montreal. During those years, it made numerous acquisitions and diversified into new product groups, including the Bausch & Lomb contact lens business.

Its sales climbed from US$2.46 billion in 2011 to an expected US$10.4 billion to US$10.5 billion for this year.



Advertisements

Latest Economic News

  • Feds launch contest for $950M 'supercluster' plan aimed at creating jobs, growth

    Economic CTV News
    OTTAWA -- The Trudeau government is opening the competition for its $950-million "supercluster" program that aims to bring together industry and academia as a way to lift the innovation economy. Economic Development Minister Navdeep Bains is adding new details about deadlines and qualifying criteria for a five-year initiative central to the feds' innovation program. Source
  • New York fines BNP Paribas $350 million in trading scheme

    Economic CTV News
    New York state regulators have fined French bank BNP Paribas $350 million, alleging bank employees for years manipulated global currency markets to benefit themselves at the expense of their customers. The New York Department of Financial Services said Wednesday that from 2007 to 2013 at least a dozen BNP Paribas traders manipulated the foreign exchange market, using chat rooms and fake trades in currencies including the South African rand, Hungarian forint and Turkish lira. Source
  • Bombardier and U.S. aerospace supplier Triumph settle legal dispute

    Economic CTV News
    MONTREAL -- Bombardier and Triumph have reached a settlement about five months after the U.S. aerospace supplier filed a $455-million lawsuit against the Quebec-based aircraft manufacturer. Details of the settlement announced Wednesday were not disclosed. Source
  • New TD call centre will create 575 jobs in Moncton, N.B., province says

    Economic CTV News
    MONCTON, N.B. -- TD has announced plans for a new call centre in Moncton, N.B., that the provincial government says will create up to 575 full-time jobs. The Toronto-based bank will receive up to $9 million in financial assistance from the government, which says the call centre will add $109-million to the province's GDP over six years. Source
  • Graco recalls My Ride 65 car seats in Canada for restraint defect

    Economic CBC News
    Graco's Canadian division is recalling 1,393 car seats with defective harness restraints. The recall affects certain "My Ride 65" model car seats manufactured between May 14, 2014 and July 30, 2014, according to a safety advisory from Graco. Source
  • Lavazza Coffee buys 80% stake in Canada's Kicking Horse

    Economic CBC News
    Italian coffee conglomerate Lavazza has bought an 80 per cent stake in B.C.-based Kicking Horse Coffee in a deal that values the company at $215 million. Elana Rosenfeld, who founded the Kicking Horse brand in 1996, will continue to own the remaining 20 per cent and will continue to be CEO of the company, which has grown to become the No. Source
  • OPEC nearing deal to extend oil output cut to March 2018

    Economic CBC News
    OPEC and non-member oil producers moved closer on Wednesday to clinching a deal on extending output cuts by nine months to clear a global stocks overhang and prop up the price of crude. The Organization of the Petroleum Exporting Countries meets in Vienna on Thursday to consider whether to prolong the accord reached in December in which OPEC and 11 non-members agreed to cut oil output by about 1.8 million barrels per day in the first half of 2017. Source
  • Moody's cuts China credit rating over rising debt

    Economic CBC News
    The Moody's ratings agency on Wednesday cut China's credit rating due to surging debt, prompting a protest by Beijing and highlighting challenges faced by communist leaders as they overhaul a slowing economy. The downgrade adds to warnings about China's reliance on credit to propel growth after the 2008 global crisis. Source
  • 'The Bank of Canada is not spooked' : Why the central bank is holding rates steady

    Economic CBC News
    The Bank of Canada kept its benchmark interest rate steady on Wednesday, but signalled that could change once the weak U.S. economy starts to rebound as expected through the latter part of the year. Canada's central bank kept its target for the overnight rate steady at 0.5 per cent on Wednesday, the same level it's been at since the middle of 2015, because the economy isn't showing any signs of needing any more or any less stimulus. Source
  • Ottawa offers $950 million for 'superclusters' to create jobs

    Economic CBC News
    The federal government is spending $950 million to fund an "Innovation Superclusters Initiative" that it says will "create more middle-class jobs and more opportunities for Canadian businesses to grow into globally successful brands." Minister of innovation, science and economic development Navdeep Bains made the announcement at the offices of BlackBerry QNX in Kanata, Ont. Source